CIRCULATION 2017

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy

Gregory P. Hess, MD, MSc Pradeep Natarajan, MD, MMSc Kamil F. Faridi, MD Anna Fievitz, BS Linda Valsdottir, MS Robert W. Yeh, MD, MSc

Previous
Previous

Acquavella et al JCSM 2020

Next
Next

Hess et al Radiation Oncology 2012